Innovator IBD 50 ETF (NYSEARCA:FFTY) Stock Short Interest Report for September

Innovator IBD 50 ETF (NYSEARCA:FFTY) saw a significant decline in short interest in September. As of September 30th, there was short interest totaling 8,533 shares, a decline of 67.4% from the September 15th total of 26,201 shares. Currently, 0.4% of the company’s stock are sold short. Based on an average daily trading volume, of 8,524 shares, the short-interest ratio is presently 1.0 days.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Kraematon Investment Advisors Inc. bought a new position in shares of Innovator IBD 50 ETF in the 2nd quarter worth $1,021,000. Guardian Wealth Advisors LLC NC purchased a new stake in shares of Innovator IBD 50 ETF during the 2nd quarter worth $507,000. Royal Bank of Canada lifted its stake in shares of Innovator IBD 50 ETF by 3,222.5% during the 1st quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock worth $611,000 after purchasing an additional 17,724 shares during the last quarter. Concurrent Investment Advisors LLC boosted its position in Innovator IBD 50 ETF by 11.1% during the second quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock valued at $3,349,000 after purchasing an additional 6,321 shares in the last quarter. Finally, Trail Ridge Investment Advisors LLC bought a new stake in Innovator IBD 50 ETF during the second quarter valued at about $210,000.

Innovator IBD 50 ETF Stock Performance

Innovator IBD 50 ETF stock traded down $0.55 during mid-day trading on Monday, reaching $35.24. 3,643 shares of the company were exchanged, compared to its average volume of 51,512. The business has a fifty day moving average of $36.11 and a 200 day moving average of $37.94. The firm has a market cap of $68.72 million, a P/E ratio of 30.34 and a beta of 1.48. Innovator IBD 50 ETF has a 12-month low of $31.61 and a 12-month high of $44.08.

About Innovator IBD 50 ETF

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.